226 related articles for article (PubMed ID: 15823563)
1. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
[TBL] [Abstract][Full Text] [Related]
2. Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif.
Nothacker HP; Wang Z; Zeng H; Mahata SK; O'Connor DT; Civelli O
Eur J Pharmacol; 2005 Sep; 519(1-2):191-3. PubMed ID: 16111673
[TBL] [Abstract][Full Text] [Related]
3. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
4. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours.
Allia E; Tarabra E; Volante M; Cerrato M; Ghigo E; Muccioli G; Papotti M
J Pathol; 2005 Nov; 207(3):336-45. PubMed ID: 16161007
[TBL] [Abstract][Full Text] [Related]
5. The Origin, Expression, Function and Future Research Focus of a G Protein-coupled Receptor, Mas-related Gene X2 (MrgX2).
Wu H; Zeng M; Cho EY; Jiang W; Sha O
Prog Histochem Cytochem; 2015 Jul; 50(1-2):11-7. PubMed ID: 26106044
[TBL] [Abstract][Full Text] [Related]
6. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
[TBL] [Abstract][Full Text] [Related]
7. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
[TBL] [Abstract][Full Text] [Related]
8. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion.
Robas N; Mead E; Fidock M
J Biol Chem; 2003 Nov; 278(45):44400-4. PubMed ID: 12915402
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine.
Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the effect of different regulatory peptides on adrenocortical cell proliferation in immature rats: evidence that endogenous adrenomedullin exerts a stimulating action.
Trejter M; Markowska A; Belloni AS; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2002 Jul; 10(1):81-4. PubMed ID: 12060855
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) in adrenal chromaffin cells.
Kobayashi H; Yanagita T; Yokoo H; Wada A
Peptides; 2001 Nov; 22(11):1895-901. PubMed ID: 11754978
[TBL] [Abstract][Full Text] [Related]
13. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin stimulates [(35)S]GTP gamma S binding in Hcrtr 2-transfected cell lines and in brain homogenate.
Shiba T; Ozu M; Yoshida Y; Mignot E; Nishino S
Biochem Biophys Res Commun; 2002 Jun; 294(3):615-20. PubMed ID: 12056812
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a human receptor for neuropeptide FF and related peptides.
Kotani M; Mollereau C; Detheux M; Le Poul E; Brézillon S; Vakili J; Mazarguil H; Vassart G; Zajac JM; Parmentier M
Br J Pharmacol; 2001 May; 133(1):138-44. PubMed ID: 11325803
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma.
Calvo A; Abasolo I; Jiménez N; Wang Z; Montuenga L
Microsc Res Tech; 2002 Apr; 57(2):98-104. PubMed ID: 11921360
[TBL] [Abstract][Full Text] [Related]
19. Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase.
Nagatomo Y; Kitamura K; Kangawa K; Fujimoto Y; Eto T
Biochem Biophys Res Commun; 1996 Jun; 223(3):539-43. PubMed ID: 8687431
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of nicotinic cholinergic receptors by proadrenomedullin N-terminal 12 peptide in bovine adrenal chromaffin cells.
Kobayashi H; Yamamoto R; Kitamura K; Kuwasako K; Minami S; Yanagita T; Shiraishi S; Yokoo H; Eto T; Wada A
Brain Res Mol Brain Res; 2001 Mar; 87(2):175-83. PubMed ID: 11245919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
